| 注册
首页|期刊导航|中国临床药理学杂志|复方倍他米松注射液耳后注射治疗突发性耳聋患者的临床研究

复方倍他米松注射液耳后注射治疗突发性耳聋患者的临床研究

周书芳 钟志生 李滇 汪旭

中国临床药理学杂志2024,Vol.40Issue(7):977-980,4.
中国临床药理学杂志2024,Vol.40Issue(7):977-980,4.DOI:10.13699/j.cnki.1001-6821.2024.07.009

复方倍他米松注射液耳后注射治疗突发性耳聋患者的临床研究

Clinical trial of postauricular injection of compound betamethasone injection in the treatment of patients with sudden deafness

周书芳 1钟志生 1李滇 1汪旭1

作者信息

  • 1. 海安市人民医院耳鼻咽喉头颈外科,江苏南通 226600
  • 折叠

摘要

Abstract

Objective To observe the efficacy of postauricular injection of compound betamethasone injection in the treatment of sudden deafness and its influence on transcranial doppler(TCD)parameters and fibrinolysis-coagulation indicators.Methods Patients with sudden deafness were divided into control group and treatment group according to cohort methed.The control group was given intravenous injection of dexamethasone sodium phosphate for 10 days on the basis of conventional treatment,and the treatment group was given postauricular injection of compound betamethasone injection 0.8 g for once every other day for 5 times in addition to conventional treatment.The clinical efficacy,hearing level,haemodynamics and laboratory indicators[homocysteine(Hcy),platelet(PLT)count]were compared between the two groups of patients,and the adverse drug reactions or complications were counted.Results There were 50 cases in treatment group and 50 cases in control group.After treatment,the total effective rates in treatment group and control group were 94.00%(47 cases/50 cases)and 80.00%(40 cases/50 cases),with significant difference(P<0.05).After treatment,the acoustic thresholds under 0.5 kHz,1 kHz,2 kHz and 4 kHz in treatment group were(42.48±5.65),(45.35±6.44),(48.67±5.58)and(50.25±6.06)dB,which in control group were(50.64±6.92),(57.66±7.41),(60.24±8.31)and(63.15±8.25)dB,all with significant difference(all P<0.05).After treatment,the whole blood high-shear viscosities in treatment group and control group were(4.18±0.58)and(4.99±0.76)mpa·s;the whole blood low-shear viscosities were(9.18±1.15)and(10.31±1.28)mpa·s;the plasma viscosities were(1.44±0.32)and(1.76±0.25)mpa·s;the Hcy levels in treatment group and control group were(15.57±4.25)and(21.75±4.93)μmol·L-1;PLT levels were(198.72±21.41)×109·L-1and(212.67±18.46)×109·L-1 respectively,all with significant difference(all P<0.05).There were no obvious adverse drug reactions in treatment group and control group.Conclusion Postauricular injection of compound betamethasone injection can improve the hearing level and enhance the clinical efficacy in patients with sudden deafness,and it is helpful to improve haemodynamics and reduce serum Hcy level,with good safety.

关键词

复方倍他米松/耳后注射/突发性耳聋/经颅多普勒超声/血流动力学

Key words

compound betamethasone/postauricular injection/sudden deafness/transcranial doppler ultrasound/haemodynamics

分类

医药卫生

引用本文复制引用

周书芳,钟志生,李滇,汪旭..复方倍他米松注射液耳后注射治疗突发性耳聋患者的临床研究[J].中国临床药理学杂志,2024,40(7):977-980,4.

中国临床药理学杂志

OA北大核心CSTPCD

1001-6821

访问量0
|
下载量0
段落导航相关论文